Ketamine infusion therapy, a groundbreaking treatment option for severe psychiatric disorders and chronic pain, has garnered significant attention and praise within the medical community. With over 50 years of FDA-approved use as an anesthetic, ketamine has proven to be a game-changer in depression research by regenerating synapses in the brain and facilitating improved communication between nerve cells.
According to Upstate Ketamine Center, a leading provider of ketamine infusion therapy, this innovative treatment is proving to have a strong safety profile with transient side effects that subside once the infusion is completed. Over 70% of patients experience notable improvements in mood and overall function soon after starting treatment, including combat veterans with post-traumatic stress disorder (PTSD). The therapy has shown remarkable efficacy in reducing depressive symptoms, chronic pain, fibromyalgia, and obsessive-compulsive disorder (OCD), among other conditions.
To undergo the treatment, patients are required to complete the necessary intake forms and receive a small IV catheter in their arm. The infusion, lasting approximately 40 minutes, is conducted under the supervision of medical professionals in a private room furnished with comfortable recliners. The number of infusions required may vary depending on the individual's needs.
Ketamine infusion therapy, with its ability to combat treatment-resistant conditions, is revolutionizing the field of depression research. Its fast-acting and effective nature has the potential to significantly improve the lives of individuals facing mental health challenges.
This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™
The reference URL for this press release is located here Upstate Ketamine Center: A Game-Changer in Depression Research.
